|
PSMD12 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.795200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.529800E-01 |
| Normal-vs-Stage2 |
6.724200E-01 |
| Normal-vs-Stage3 |
3.773400E-01 |
| Normal-vs-Stage4 |
5.260200E-01 |
| Stage1-vs-Stage2 |
7.876000E-01 |
| Stage1-vs-Stage3 |
4.521000E-01 |
| Stage1-vs-Stage4 |
6.627000E-01 |
| Stage2-vs-Stage3 |
8.635400E-01 |
| Stage2-vs-Stage4 |
9.911800E-01 |
| Stage3-vs-Stage4 |
8.376800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.120600E-01 |
| Normal-vs-AfricanAmerican |
5.439900E-03 |
| Normal-vs-Asian |
8.853000E-01 |
| Caucasian-vs-AfricanAmerican |
3.400600E-03 |
| Caucasian-vs-Asian |
8.368800E-01 |
| AfricanAmerican-vs-Asian |
1.710820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.076200E-01 |
| Normal-vs-Female |
7.233400E-01 |
| Male-vs-Female |
6.904200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.248590E-01 |
| Normal-vs-Age(41-60Yrs) |
4.780600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.839200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.888000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.024000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.559000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.682200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.012400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.310000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.277800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.717800E-01 |
| Normal-vs-Grade 2 |
6.479600E-01 |
| Normal-vs-Grade 3 |
7.882000E-02 |
| Normal-vs-Grade 4 |
5.060800E-01 |
| Grade 1-vs-Grade 2 |
8.283400E-01 |
| Grade 1-vs-Grade 3 |
1.564970E-01 |
| Grade 1-vs-Grade 4 |
4.638000E-01 |
| Grade 2-vs-Grade 3 |
1.245700E-02 |
| Grade 2-vs-Grade 4 |
3.193400E-01 |
| Grade 3-vs-Grade 4 |
5.200200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.051210E-01 |
| Normal-vs-ccB subtype |
1.244420E-01 |
| ccA subtype-vs-ccB subtype |
1.020220E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.803800E-01 |
| Normal-vs-N1 |
7.514600E-01 |
| N0-vs-N1 |
5.620400E-01 |
|
|
